-
EP3771718
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3771718
| EP3771718 - PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN [Right-click to bookmark this link] | Status | The application has been refused Status updated on 25.06.2021 Database last updated on 24.08.2024 | |
| Former | The application has been published Status updated on 01.01.2021 | Most recent event Tooltip | 25.06.2021 | Refusal of application | published on 28.07.2021 [2021/30] | Applicant(s) | For all designated states Lexicon Pharmaceuticals, Inc. 8800 Technology Forest Place The Woodlands, TX 77381 / US | [2021/05] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [N/P] |
| Former [2021/05] | Abel & Imray Westpoint Building James Street West Bath BA1 2DA / GB | Application number, filing date | 19305999.5 | 01.08.2019 | [2021/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3771718 | Date: | 03.02.2021 | Language: | EN | [2021/05] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.10.2019 | Classification | IPC: | C07H1/06, C07H7/04, C07H13/08, A61P3/10 | [2021/05] | CPC: |
C07H1/06 (EP,CN,IL,US);
C07H13/08 (EP,IL,KR,US);
A61P3/10 (EP,CN,IL);
C07D309/10 (CN);
C07H1/00 (KR);
C07H15/14 (CN,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/05] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERFAHREN ZUR HERSTELLUNG DER KRISTALLINEN FORM II VON SOTAGLIFLOZIN | [2021/05] | English: | PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN | [2021/05] | French: | PROCÉDÉ DE PRÉPARATION DE LA FORME CRISTALLINE II DE SOTAGLIFLOZINE | [2021/05] | Examination procedure | 23.02.2021 | Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2021/30] | 05.03.2021 | Application refused, date of legal effect [2021/30] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]WO2010009197 (LEXICON PHARMACEUTICALS INC [US], et al); | [Y]WO2018067805 (TEVA PHARMA [IL], et al); | [Y]EP3466958 (CRYSTAL PHARMACEUTICAL SUZHOU CO LTD [CN]) | by applicant | WO2010009197 |